The lipid-lowering effect of sacubitril valsartan combined with rosuvastatin on patients with acute coronary syndrome after PCI and its impact on the cardiovascular outcomes

NIU Xueyan, a, HUANG Zhimingb, CHEN Feia, SONG Haoming

主办:上海医药工业研究院
   中国药学会
ISSN 1672-9188   CN 31-1939/R   SLYHAA
World Clinical Drug ›› 2026, Vol. 47 ›› Issue (4) : 385. DOI: 10.13683/j.wph.2026.04.006
Article

The lipid-lowering effect of sacubitril valsartan combined with rosuvastatin on patients with acute coronary syndrome after PCI and its impact on the cardiovascular outcomes

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2026, 47(4): 385 https://doi.org/10.13683/j.wph.2026.04.006

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}

Accesses

Citation

Detail

Sections
Recommended

/